Teknova
Company

Last deal

$15.4M

Amount

Post-IPO Equity

Stage

11.07.2024

Date

2

all rounds

$38.3M

Total amount

date founded

Financing round

General

About Company
Teknova is a biotech company that provides critical reagents for bioprocessing, bioproduction, and molecular diagnostics.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Alpha Teknova

founded date

01.01.1996

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Teknova offers a wide range of products, including DNA sequencing, clone testing, and clone-based crop research services. The company's product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. Teknova's R&D team provides expertise from prototype product design to guidance on GMP manufacturing of media, buffers, and reagents for the entire gene therapy workflow. The company's products are manufactured in ISO 13485:2016 certified facilities that are US FDA 21 CPR Part 820 compliant and FDA registered. Teknova's headquarters and research services facility are located near the San Francisco Bay Area in Hollister, CA, USA, with additional facilities in Mansfield, MA, USA.
Contacts
Legal Names

Legal name

Alpha Teknova, Inc..
Similar Companies
1000
RMBIO

RMBIO

Rocky Mountain Biologicals (RMBIO) develops and produces high-performance cell culture media components.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Manufacturing, Pharmaceuticals

Location

Missoula, MT, USA
Aldevron

Aldevron

Aldevron provides contract manufacturing and scientific services.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Life Science, Biopharma

Location

Fargo, ND, USA

total rounds

2

Mediatech Inc.

Mediatech, Inc. is a leading Life Science company providing research and production support.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Manassas, VA, USA
Empirical Bioscience

Empirical Bioscience

Empirical Bioscience designs and manufactures high-grade molecular biology products used in PCR of human, animal, and plant DNA.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Grand Rapids, MI, USA

total rounds

2
M&A Details
1

Acquired by

Telegraph Hill Partners

announced date

01.01.2019

Financials

Funding Rounds
2
2

Number of Funding Rounds

$38.3M

Money Raised

Their latest funding was raised on 11.07.2024. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
11.07.2024
$15.4M
18.09.2023
$22.9M
Co-Investors

People

Employee Profiles
9

Ernesto Montes

Human resources associate

Scott Bass

Senior automation engineer

Laura Arballo

Purchasing agent and master scheduler

Ted Davis

CEO & Founder

Activity

Recent News
0